Clinical trial Recruiting at 1 site Interventional Ages 1 Month to 18

Plasma exchange for severely ill kids with sepsis

Official title: Therapeutic Plasma Exchange in Children With Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial

Run by Menoufia University · NCT07706413 · Data updated 2026-11-12

This trial tests whether adding therapeutic plasma exchange to standard sepsis care helps critically ill children with severe sepsis or septic shock.

Quick facts

Study typeInterventional
Ages1 Month to 18 Years
SexAll
Enrollment22 (estimated)
SponsorMenoufia University
Academic / other
Locations1 site (Shibīn al Kawm, Menoufia Governorate)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedFebruary 28, 2027
Study endsMarch 31, 2027
Registry record updatedOctober 7, 2026
Trial IDNCT07706413 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children from 1 month up to 18 years with a confirmed diagnosis of severe sepsis or septic shock.

Probably not a fit

Patients without sepsis or septic shock, or those with contraindications to plasma exchange, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized trial compares standard sepsis care alone to standard care plus therapeutic plasma exchange (TPE) in children with severe sepsis or septic shock admitted to a PICU. Participants are randomized to receive daily TPE sessions (1–5 sessions) within 24 hours of diagnosis, using 1-1.5 plasma volumes per session with fresh frozen plasma replacement. Outcomes include organ dysfunction (pSOFA), duration of vasopressors, PICU length of stay, time to hemodynamic stabilization, and inflammatory/coagulation biomarkers. The study is open-label and conducted at Menoufia University Hospital's PICU between August 2026 and February 2027. Adverse events from TPE will be monitored and managed per PICU protocols.

Why it matters

Potential benefit: If successful, TPE could reduce organ failure and shorten PICU stays for children with severe sepsis or septic shock.

How similar studies have gone: Previous similar approaches are being explored, but evidence in pediatric sepsis remains limited and this study aims to contribute new data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. From one month to 18 years.
2. With an established diagnosis of severe sepsis or septic shock according to international pediatric sepsis definitions.

Exclusion Criteria:

1. Known congenital bleeding disorders and severe uncontrolled hemorrhage.
2. End-stage chronic illness with expected survival \< 3 months.
3. Previous plasma exchange during the same admission.
4. Contraindications to central venous catheterization.

Where it's running

  • Menoufia university hospital, Pediatric intensive care unit
    Shibīn al Kawm, Menoufia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.